EcoDrugPlus

Adrenoceptor Alpha 1b

Ensembl ID : ENSDNOG00000017631
Gene Symbol: ADRA1B
2 Cross references
265 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSDNOG00000031287
Gene Symbol: ADRA2A
4 Cross references
227 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSDNOG00000040376
Gene Symbol: ADRA2B
4 Cross references
222 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSDNOG00000040642
Gene Symbol: ADRB2
4 Cross references
265 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSDNOG00000038161
Gene Symbol: ADRB3
3 Cross references
218 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSDNOG00000034611
Gene Symbol: AGER
2 Cross references
170 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSDNOG00000003675
Gene Symbol: ADH5
3 Cross references
409 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSDNOG00000011358
Gene Symbol: AKR1B1
2 Cross references
426 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSDNOG00000036180
Gene Symbol: GAA
2 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSDNOG00000049392
Gene Symbol: AOC1
4 Cross references
233 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSDNOG00000025112
Gene Symbol: APP
4 Cross references
279 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSDNOG00000049635
Gene Symbol: AR
4 Cross references
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).